Clinical Trials Directory

Trials / Completed

CompletedNCT04446325

Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis

Status
Completed
Phase
Study type
Observational
Enrollment
227 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Venous thrombo-embolic (VTE) rates could be high in patients with amyotrophic lateral sclerosis (ALS). Indeed, the rate of VTE in this specific population could be 7-fold higher in this population. Predictiv factors of VTE in patients with ALS are mobility reduction and neurological paralysis. However, to our knowledge, medical littérature is poor concerning VTE and ALS association. Our first aim is to define annual rate of VTE in ALS population.Then we aim to identify predictiv factors of VTE in this specific population. The studied population is Brest universitary hospital cohort of ALS patient included between 2000 and 2019.

Conditions

Timeline

Start date
2020-03-01
Primary completion
2020-03-01
Completion
2020-05-01
First posted
2020-06-24
Last updated
2020-09-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04446325. Inclusion in this directory is not an endorsement.